药品注册申请号:075292
申请类型:ANDA (仿制药申请)
申请人:SOLIS PHARMS
申请人全名:SOLIS PHARMACEUTICALS INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML No No AA 2002/02/07 2002/02/07 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2002/02/07 ORIG-1(原始申请) Approval
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2023/08/18 SUPPL-24(补充) Approval Labeling-Patient Package Insert,Labeling-Medication Guide,Labeling-Package Insert STANDARD
2023/08/09 SUPPL-23(补充) Approval Labeling-Package Insert,Labeling-Container/Carton Labels,Labeling-Medication Guide STANDARD
2021/09/20 SUPPL-21(补充) Approval Labeling-Package Insert STANDARD
2021/09/12 SUPPL-20(补充) Approval Labeling-Package Insert,Labeling-Medication Guide STANDARD
2017/01/04 SUPPL-19(补充) Approval Labeling-Package Insert STANDARD
2014/09/02 SUPPL-18(补充) Approval Labeling-Package Insert STANDARD
2012/05/29 SUPPL-17(补充) Approval Labeling-Package Insert
2008/12/02 SUPPL-15(补充) Approval Labeling
2007/06/29 SUPPL-12(补充) Approval Labeling
2007/06/29 SUPPL-11(补充) Approval Labeling
2006/08/29 SUPPL-10(补充) Approval Labeling
2006/08/29 SUPPL-9(补充) Approval Labeling
2006/03/15 SUPPL-7(补充) Approval Labeling
2005/05/17 SUPPL-5(补充) Approval Labeling
2005/05/17 SUPPL-4(补充) Approval Labeling
2002/09/03 SUPPL-1(补充) Approval Manufacturing (CMC)-Facility
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
>>>活性成分:FLUOXETINE HYDROCHLORIDE; 剂型/给药途径:SOLUTION;ORAL; 规格:EQ 20MG BASE/5ML; 治疗等效代码:AA<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
075506 001 ANDA FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML Prescription No No AA 2001/08/02 TEVA
076015 001 ANDA FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML Prescription No Yes AA 2002/01/30 PHARM ASSOC
075292 001 ANDA FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML Prescription No No AA 2002/02/07 SOLIS PHARMS
075525 001 ANDA FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML Prescription No No AA 2002/06/27 SCIEGEN PHARMS INC
075514 001 ANDA FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML Discontinued No No AA 2002/08/29 PHARMOBEDIENT CNSLTG
077849 001 ANDA FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML Prescription No No AA 2007/02/09 LANNETT CO INC
079209 001 ANDA FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML Prescription No No AA 2009/03/20 AUROBINDO PHARMA
216448 001 ANDA FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML Prescription No No AA 2022/11/09 NOVITIUM PHARMA
216953 001 ANDA FLUOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE SOLUTION;ORAL EQ 20MG BASE/5ML Prescription No No AA 2022/11/15 UPSHER SMITH LABS
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database